Sign in

CIK 0001637715

  • Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472309515
Phone
+1 720-307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-21 Leverone Jason A. Chief Financial Officer Sale −302 $2.97 $898 18,500
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy −5,781 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy +5,781 5,781
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −5,322 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +5,322 5,322
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −130,611 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +130,611 130,611
2026-06-22 Leverone Jason A. Chief Financial Officer Sale −303 $4.40 $1K 18,802
2026-04-01 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2026-03-23 Leverone Jason A. Chief Financial Officer Sale −301 $4.16 $1K 16,000
2025-12-22 Leverone Jason A. Chief Financial Officer Sale −302 $2.97 $896 16,301
2025-09-22 Leverone Jason A. Chief Financial Officer Sale −303 $2.62 $795 12,603
2025-06-23 Leverone Jason A. Chief Financial Officer Sale −303 $2.38 $722 12,906
2025-04-07 Leverone Jason A. Chief Financial Officer Sale −1,844 $2.67 $5K 13,209
2025-04-04 Leverone Jason A. Chief Financial Officer Sale −1,278 $3.33 $4K 15,053
2025-01-27 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +65,000 65,000
2024-10-04 Leverone Jason A. Chief Financial Officer Grant or award +16,331 16,331
2024-10-04 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +5,781 5,781
2024-10-04 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +5,322 5,322

Page 1 of 2 · 21 trades